These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16945386)

  • 21. Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead.
    Iyengar AR; Pande AH
    Protein J; 2016 Dec; 35(6):424-439. PubMed ID: 27830420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.
    Abou-Donia MB; Siracuse B; Gupta N; Sobel Sokol A
    Crit Rev Toxicol; 2016 Nov; 46(10):845-875. PubMed ID: 27705071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postponed effect of neostigmine on oxidative homeostasis.
    Pohanka M
    Interdiscip Toxicol; 2014 Sep; 7(3):134-8. PubMed ID: 26109890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.
    Gore A; Bloch-Shilderman E; Egoz I; Turetz J; Brandeis R
    Br J Pharmacol; 2014 May; 171(9):2364-74. PubMed ID: 24428128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic Insights into the Hydrolysis of Organophosphorus Compounds by Paraoxonase-1: Exploring the Limits of Substrate Tolerance in a Promiscuous Enzyme.
    Muthukrishnan S; Shete VS; Sanan TT; Vyas S; Oottikkal S; Porter LM; Magliery TJ; Hadad CM
    J Phys Org Chem; 2012 Dec; 25(12):1247-1260. PubMed ID: 23946555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the treatment of organophosphorous poisonings.
    Balali-Mood M; Saber H
    Iran J Med Sci; 2012 Jun; 37(2):74-91. PubMed ID: 23115436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tulsa oklahoma oktoberfest tent collapse report.
    Deal KE; Synovitz CK; Goodloe JM; King B; Stewart CE
    Emerg Med Int; 2012; 2012():729795. PubMed ID: 22649732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical and bidirectional drug effects.
    Smith SW; Hauben M; Aronson JK
    Drug Saf; 2012 Mar; 35(3):173-89. PubMed ID: 22272687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [+]-Huperzine A protects against soman toxicity in guinea pigs.
    Wang Y; Wei Y; Oguntayo S; Jensen N; Doctor BP; Nambiar MP
    Neurochem Res; 2011 Dec; 36(12):2381-90. PubMed ID: 21822920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VX hydrolysis by human serum paraoxonase 1: a comparison of experimental and computational results.
    Peterson MW; Fairchild SZ; Otto TC; Mohtashemi M; Cerasoli DM; Chang WE
    PLoS One; 2011; 6(5):e20335. PubMed ID: 21655255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents.
    Geyer BC; Kannan L; Garnaud PE; Broomfield CA; Cadieux CL; Cherni I; Hodgins SM; Kasten SA; Kelley K; Kilbourne J; Oliver ZP; Otto TC; Puffenberger I; Reeves TE; Robbins N; Woods RR; Soreq H; Lenz DE; Cerasoli DM; Mor TS
    Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20251-6. PubMed ID: 21059932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational characterization of how the VX nerve agent binds human serum paraoxonase 1.
    Fairchild SZ; Peterson MW; Hamza A; Zhan CG; Cerasoli DM; Chang WE
    J Mol Model; 2011 Jan; 17(1):97-109. PubMed ID: 20379755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain.
    Johnson ND; Duysen EG; Lockridge O
    Neurotoxicology; 2009 May; 30(3):386-92. PubMed ID: 19442823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiological and clinical aspects of combat anticholinesterase poisoning.
    Weinbroum AA
    Br Med Bull; 2004; 72():119-33. PubMed ID: 15845747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organic phosphorus compounds--nerve agents.
    Barthold CL; Schier JG
    Crit Care Clin; 2005 Oct; 21(4):673-89, v-vi. PubMed ID: 16168308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Karasova J
    Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarin experiences in Japan: acute toxicity and long-term effects.
    Yanagisawa N; Morita H; Nakajima T
    J Neurol Sci; 2006 Nov; 249(1):76-85. PubMed ID: 16962140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nerve agents: implications for anesthesia providers.
    Hrobak PK
    AANA J; 2008 Apr; 76(2):95-7. PubMed ID: 18478812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acute treatment of nerve agent exposure.
    Cannard K
    J Neurol Sci; 2006 Nov; 249(1):86-94. PubMed ID: 16945386
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.